These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 12595271)
1. Efficient conformational sampling of local side-chain flexibility. Källblad P; Dean PM J Mol Biol; 2003 Mar; 326(5):1651-65. PubMed ID: 12595271 [TBL] [Abstract][Full Text] [Related]
2. Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors. Lovejoy B; Welch AR; Carr S; Luong C; Broka C; Hendricks RT; Campbell JA; Walker KA; Martin R; Van Wart H; Browner MF Nat Struct Biol; 1999 Mar; 6(3):217-21. PubMed ID: 10074939 [TBL] [Abstract][Full Text] [Related]
3. Receptor flexibility in de novo ligand design and docking. Alberts IL; Todorov NP; Dean PM J Med Chem; 2005 Oct; 48(21):6585-96. PubMed ID: 16220975 [TBL] [Abstract][Full Text] [Related]
4. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor. Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126 [TBL] [Abstract][Full Text] [Related]
5. Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8). Pochetti G; Montanari R; Gege C; Chevrier C; Taveras AG; Mazza F J Med Chem; 2009 Feb; 52(4):1040-9. PubMed ID: 19173605 [TBL] [Abstract][Full Text] [Related]
6. Receptor flexibility in the in silico screening of reagents in the S1' pocket of human collagenase. Källblad P; Todorov NP; Willems HM; Alberts IL J Med Chem; 2004 May; 47(11):2761-7. PubMed ID: 15139754 [TBL] [Abstract][Full Text] [Related]
8. Binary image representation of a ligand binding site: its application to efficient sampling of a conformational ensemble. Sung E; Kim S; Shin W BMC Bioinformatics; 2010 May; 11():256. PubMed ID: 20478076 [TBL] [Abstract][Full Text] [Related]
9. De novo ligand design to an ensemble of protein structures. Todorov NP; Buenemann CL; Alberts IL Proteins; 2006 Jul; 64(1):43-59. PubMed ID: 16555306 [TBL] [Abstract][Full Text] [Related]
10. Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1. Zhang X; Gonnella NC; Koehn J; Pathak N; Ganu V; Melton R; Parker D; Hu SI; Nam KY J Mol Biol; 2000 Aug; 301(2):513-24. PubMed ID: 10926524 [TBL] [Abstract][Full Text] [Related]
11. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors. Kiyama R; Tamura Y; Watanabe F; Tsuzuki H; Ohtani M; Yodo M J Med Chem; 1999 May; 42(10):1723-38. PubMed ID: 10346925 [TBL] [Abstract][Full Text] [Related]
12. The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling. Park HI; Jin Y; Hurst DR; Monroe CA; Lee S; Schwartz MA; Sang QX J Biol Chem; 2003 Dec; 278(51):51646-53. PubMed ID: 14532275 [TBL] [Abstract][Full Text] [Related]
13. Impact of mobility on structure-based drug design for the MMPs. Moy FJ; Chanda PK; Chen J; Cosmi S; Edris W; Levin JI; Rush TS; Wilhelm J; Powers R J Am Chem Soc; 2002 Oct; 124(43):12658-9. PubMed ID: 12392402 [TBL] [Abstract][Full Text] [Related]
14. FlexE: efficient molecular docking considering protein structure variations. Claussen H; Buning C; Rarey M; Lengauer T J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774 [TBL] [Abstract][Full Text] [Related]
15. Tetrahydroisoquinoline-3-carboxylate based matrix-metalloproteinase inhibitors: design, synthesis and structure-activity relationship. Matter H; Schudok M; Schwab W; Thorwart W; Barbier D; Billen G; Haase B; Neises B; Weithmann K; Wollmann T Bioorg Med Chem; 2002 Nov; 10(11):3529-44. PubMed ID: 12213468 [TBL] [Abstract][Full Text] [Related]
17. Structural basis for the highly selective inhibition of MMP-13. Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645 [TBL] [Abstract][Full Text] [Related]
18. Testing a flexible-receptor docking algorithm in a model binding site. Wei BQ; Weaver LH; Ferrari AM; Matthews BW; Shoichet BK J Mol Biol; 2004 Apr; 337(5):1161-82. PubMed ID: 15046985 [TBL] [Abstract][Full Text] [Related]
19. X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin. Dunten P; Kammlott U; Crowther R; Levin W; Foley LH; Wang P; Palermo R Protein Sci; 2001 May; 10(5):923-6. PubMed ID: 11316871 [TBL] [Abstract][Full Text] [Related]
20. Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: implications for drug design. Gavuzzo E; Pochetti G; Mazza F; Gallina C; Gorini B; D'Alessio S; Pieper M; Tschesche H; Tucker PA J Med Chem; 2000 Sep; 43(18):3377-85. PubMed ID: 10978185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]